Cellectis says genomic surgery can be used to make biofuels

According to French media reports, recently, Andre Choulika, president of the French large-scale biotechnology company Cellectis, said in an interview with Reuters that the company will prove genomic surgery from now until January 2013 It is possible to use microalgae to make third-generation biofuels. At present, Cellectis should mainly prove the effectiveness of its technology in algae plants.

In July 2009, Exxon Mobil signed a cooperation agreement with Synthetic Genomics of California Biotechnology Research Group, and formed a competition with Cellectis and Total. relationship. To develop an alternative biofuel based on algae, ExxonMobil plans to invest US $ 600 million.

Cellectis has developed molecular scissors that can interfere with deoxyribonucleic acid (ADN). Through this molecular scissors, the company can change or replace disease mutation vector genes and change plant organisms. The company is also responsible for the commercialization of molecular scissors. The company has extended the technology to academic research in the biological production, agriculture and pharmaceutical industries. In addition, the company also cooperates with Merck, AstraZeneca, Regeneron, BASF, and Monsanto. ) And the Swiss Novartis pharmaceutical company (Novartis) established a cooperative relationship.

Cassrole

Oven Casserole,Tater Tot Casserole,Casserole Cookware,Mini Casserole Pots

Guangdong Qunfa Ceramics Co., Ltd , https://www.qunfaceramics.com

Posted on